Last update 19 Sep 2026

IRDye800CW-nimotuzumab

Overview

Basic Info

Drug Type
Antibody-photosensitizer conjugates
Synonyms-
Target
EGFR
Action
antagonists
Mechanism
EGFR antagonists(Epidermal growth factor receptor erbB1 antagonists)
Therapeutic Areas
NeoplasmsRespiratory DiseasesOther Diseases
Active Indication
Contrast agentsResectable Lung Non-Small Cell Carcinoma
Inactive Indication-
Originator Organization
University of SaskatchewanUniversity of Saskatchewan
Active Organization
University of SaskatchewanUniversity of Saskatchewan
Inactive Organization-
License Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Boost your research with our ADC technology data.
login
or
view full example data
Boost your research with our ADC technology data.

Related

1
Clinical Trials associated with IRDye800CW-nimotuzumab
NCT04459065
/ RecruitingPhase 1/2IIT
Evaluation of IRDye800CW-nimotuzumab in Lung Cancer Surgery
100 Clinical Results associated with IRDye800CW-nimotuzumab
Login to view more data
100 Translational Medicine associated with IRDye800CW-nimotuzumab
Login to view more data
100 Patents (Medical) associated with IRDye800CW-nimotuzumab
Login to view more data
100 Deals associated with IRDye800CW-nimotuzumab
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Resectable Lung Non-Small Cell CarcinomaPhase 2
Canada
University of SaskatchewanUniversity of Saskatchewan
01 Sep 2020
Contrast agentsPhase 2-
University of SaskatchewanUniversity of Saskatchewan
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free